Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes
NCT: NCT07729150 · NOT_YET_RECRUITING
Brief Summary
This is a prospective, randomized, non-pharmacologic interventional trial evaluating the effectiveness of the Embr Wave wearable thermal device in reducing hot flash burden in men with prostate cancer receiving androgen deprivation therapy (ADT). Participants will be randomized 1:1 to immediate (12 weeks) versus delayed (after 6 weeks) use of the Embr Wave device. The study aims to determine whether the device reduces vasomotor symptoms using a number of patient-reported outcomes
Frequently Asked Questions
What is Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes?
Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes is a clinical trial registered under NCT07729150. Current status: NOT_YET_RECRUITING.
What is the status of NCT07729150?
The current status of NCT07729150 (Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes) is: NOT_YET_RECRUITING.
When did Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes start?
Reduce HEAT: A Randomized Trial of Wearable Thermal Devices for ADT-Induced Hot Flashes started on 2026-10-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.